Sterol regulatory element binding protein-1 (SREBP1) activation in motor neurons in excitotoxicity and amyotrophic lateral sclerosis (ALS): Indip, a potential therapeutic peptide

Biochemical and Biophysical Research Communications

Volumn 413, Issue 2, 2011, Pages 159-163

  Taghibiglou, Changiz ^a   Lu, Jie ^a   Mackenzie, Ian R ^a   Wang, Yu Tian ^a   Cashman, Neil R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

ALS; Insig 1; Neuronal excitotoxicity; Neuroprotection; SREBP1

Indexed keywords

INDIP; INSIG 1 PROTEIN; MEMBRANE PROTEIN; NEUROPROTECTIVE AGENT; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; CELL ACTIVATION; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; EXCITOTOXICITY; FEMALE; MALE; MOTONEURON; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SPINAL CORD;

AMINO ACID SEQUENCE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CELLS, CULTURED; CYTOPROTECTION; GLUTAMIC ACID; HUMANS; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; MOTOR NEURONS; NEUROTOXINS; PEPTIDES; SPINAL CORD; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

MUS MUSCULUS;

EID: 80053122133     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.08.011     Document Type: Article

References (41)

1. Cleveland D.W., Rothstein J.D. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat. Rev. Neurosci. 2001, 2:806-819.
2. Boillee S., Vande Velde C., Cleveland D.W. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 2006, 52:39-59.
3. Strong M.J., Kesavapany S., Pant H.C. The pathobiology of amyotrophic lateral sclerosis: a proteinopathy?. J. Neuropathol. Exp. Neurol. 2005, 64:649-664.
4. Atkin J.D., Farg M.A., Turner B.J., Tomas D., Lysaght J.A., Nunan J., Rembach A., Nagley P., Beart P.M., Cheema S.S., Horne M.K. Induction of the unfolded protein response in familial amyotrophic lateral sclerosis and association of protein-disulfide isomerase with superoxide dismutase 1. J. Biol. Chem. 2006, 281:30152-30165.
5. Turner B.J., Atkin J.D. ER stress and UPR in familial amyotrophic lateral sclerosis. Curr. Mol. Med. 2006, 6:79-86.
6. Ilieva E.V., Ayala V., Jove M., Dalfo E., Cacabelos D., Povedano M., Bellmunt M.J., Ferrer I., Pamplona R., Portero-Otin M. Oxidative and endoplasmic reticulum stress interplay in sporadic amyotrophic lateral sclerosis. Brain 2007, 130:3111-3123.
7. Foran E., Trotti D. Glutamate transporters and the excitotoxic path to motor neuron degeneration in amyotrophic lateral sclerosis. Antioxid. Redox Signal. 2009, 11:1587-1602.
8. Vucic S., Kiernan M.C. Pathophysiology of neurodegeneration in familial amyotrophic lateral sclerosis. Curr. Mol. Med. 2009, 9:255-272.
9. Brooks B.R. Managing amyotrophic lateral sclerosis: slowing disease progression and improving patient quality of life. Ann. Neurol. 2009, 65(Suppl. l):S17-23.
10. Zinman L., Cudkowicz M. Emerging targets and treatments in amyotrophic lateral sclerosis. Lancet Neurol. 2011, 10:481-490.
11. Zhong Z., Ilieva H., Hallagan L., Bell R., Singh I., Paquette N., Thiyagarajan M., Deane R., Fernandez J.A., Lane S., Zlokovic A.B., Liu T., Griffin J.H., Chow N., Castellino F.J., Stojanovic K., Cleveland D.W., Zlokovic B.V. Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cells. J. Clin. Invest. 2009, 119:3437-3449.
12. Vargas M.R., Johnson D.A., Sirkis D.W., Messing A., Johnson J.A. Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis. J. Neurosci. 2008, 28:13574-13581.
13. Kiaei M. Peroxisome proliferator-activated receptor-gamma in amyotrophic lateral sclerosis and Huntington's disease. PPAR Res. 2008, 2008:418765.
14. Eve D.J., Dennis J.S., Citron B.A. Transcription factor p53 in degenerating spinal cords. Brain Res. 2007, 1150:174-181.
15. Vlug A.S., Teuling E., Haasdijk E.D., French P., Hoogenraad C.C., Jaarsma D. ATF3 expression precedes death of spinal motoneurons in amyotrophic lateral sclerosis-SOD1 transgenic mice and correlates with c-Jun phosphorylation, CHOP expression, somato-dendritic ubiquitination and Golgi fragmentation. Eur. J. Neurosci. 2005, 22:1881-1894.
16. Jaarsma D., Holstege J.C., Troost D., Davis M., Kennis J., Haasdijk E.D., De Jong V.J. Induction of c-Jun immunoreactivity in spinal cord and brainstem neurons in a transgenic mouse model for amyotrophic lateral sclerosis. Neurosci. Lett. 1996, 219:179-182.
17. Zhai J., Lin H., Canete-Soler R., Schlaepfer W.W. HoxB2 binds mutant SOD1 and is altered in transgenic model of ALS. Hum. Mol. Genet. 2005, 14:2629-2640.
18. Batulan Z., Shinder G.A., Minotti S., He B.P., Doroudchi M.M., Nalbantoglu J., Strong M.J., Durham H.D. High threshold for induction of the stress response in motor neurons is associated with failure to activate HSF1. J. Neurosci. 2003, 23:5789-5798.
19. Chung Y.H., Joo K.M., Lee Y.J., Kim M.J., Cha C.I. Reactive astrocytes express cAMP-response-element-binding protein (CREB) binding protein (CBP) in the central nervous system of transgenic mice expressing a human Cu/Zn superoxide dismutase mutation. Neurosci. Lett. 2003, 343:159-162.
20. Migheli A., Piva R., Atzori C., Troost D., Schiffer D. c-Jun, JNK/SAPK kinases and transcription factor NF-kappa B are selectively activated in astrocytes, but not motor neurons, in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 1997, 56:1314-1322.
21. Taghibiglou C., Martin H.G., Lai T.W., Cho T., Prasad S., Kojic L., Lu J., Liu Y., Lo E., Zhang S., Wu J.Z., Li Y.P., Wen Y.H., Imm J.H., Cynader M.S., Wang Y.T. Role of NMDA receptor-dependent activation of SREBP1 in excitotoxic and ischemic neuronal injuries. Nat. Med. 2009, 15:1399-1406.
22. Goldstein J.L., DeBose-Boyd R.A., Brown M.S. Protein sensors for membrane sterols. Cell 2006, 124:35-46.
23. Gong Y., Lee J.N., Lee P.C., Goldstein J.L., Brown M.S., Ye J. Sterol-regulated ubiquitination and degradation of Insig-1 creates a convergent mechanism for feedback control of cholesterol synthesis and uptake. Cell Metab. 2006, 3:15-24.
24. Lee J.N., Ye J. Proteolytic activation of sterol regulatory element-binding protein induced by cellular stress through depletion of Insig-1. J. Biol. Chem. 2004, 279:45257-45265.
25. Anderson K.N., Potter A.C., Piccenna L.G., Quah A.K., Davies K.E., Cheema S.S. Isolation and culture of motor neurons from the newborn mouse spinal cord. Brain Res. Brain Res. Protoc. 2004, 12:132-136.
26. Brewer G.J. Isolation and culture of adult rat hippocampal neurons. J. Neurosci. Methods 1997, 71:143-155.
27. Lau A., Tymianski M. Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch. 2010, 460:525-542.
28. Wang Y., Qin Z.H. Molecular and cellular mechanisms of excitotoxic neuronal death. Apoptosis 2010, 15:1382-1402.
29. Bogaert E., d'Ydewalle C., Van Den Bosch L. Amyotrophic lateral sclerosis and excitotoxicity: from pathological mechanism to therapeutic target. CNS Neurol. Disord. Drug Targets 2010, 9:297-304.
30. Wang H., Kouri G., Wollheim C.B. ER stress and SREBP-1 activation are implicated in beta-cell glucolipotoxicity. J. Cell Sci. 2005, 118:3905-3915.
31. Taghibiglou C., Martin H.G., Rose J.K., Ivanova N., Lin C.H., Lau H.L., Rai S., Wang Y.T., Rankin C.H. Essential role of SBP-1 activation in oxygen deprivation induced lipid accumulation and increase in body width/length ratio in Caenorhabditis elegans. FEBS Lett. 2009, 583:831-834.
32. Chang Y.C., Bien C.M., Lee H., Espenshade P.J., Kwon-Chung K.J. Sre1p, a regulator of oxygen sensing and sterol homeostasis, is required for virulence in Cryptococcus neoformans. Mol. Microbiol. 2007, 64:614-629.
33. Todd B.L., Stewart E.V., Burg J.S., Hughes A.L., Espenshade P.J. Sterol regulatory element binding protein is a principal regulator of anaerobic gene expression in fission yeast. Mol. Cell. Biol. 2006, 26:2817-2831.
34. Oosthuyse B., Moons L., Storkebaum E., Beck H., Nuyens D., Brusselmans K., Van Dorpe J., Hellings P., Gorselink M., Heymans S., Theilmeier G., Dewerchin M., Laudenbach V., Vermylen P., Raat H., Acker T., Vleminckx V., Van Den Bosch L., Cashman N., Fujisawa H., Drost M.R., Sciot R., Bruyninckx F., Hicklin D.J., Ince C., Gressens P., Lupu F., Plate K.H., Robberecht W., Herbert J.M., Collen D., Carmeliet P. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat. Genet. 2001, 28:131-138.
35. Sebastia J., Kieran D., Breen B., King M.A., Netteland D.F., Joyce D., Fitzpatrick S.F., Taylor C.T., Prehn J.H. Angiogenin protects motoneurons against hypoxic injury. Cell Death Differ. 2009, 16:1238-1247.
36. Bergmann F., Keller B.U. Impact of mitochondrial inhibition on excitability and cytosolic Ca2+ levels in brainstem motoneurones from mouse. J. Physiol. 2004, 555:45-59.
37. O'Reilly J.P., Jiang C., Haddad G.G. Major differences in response to graded hypoxia between hypoglossal and neocortical neurons. Brain Res. 1995, 683:179-186.
38. Park K.G., Min A.K., Koh E.H., Kim H.S., Kim M.O., Park H.S., Kim Y.D., Yoon T.S., Jang B.K., Hwang J.S., Kim J.B., Choi H.S., Park J.Y., Lee I.K., Lee K.U. Alpha-lipoic acid decreases hepatic lipogenesis through adenosine monophosphate-activated protein kinase (AMPK)-dependent and AMPK-independent pathways. Hepatology 2008, 48:1477-1486.
39. Dupuis L., Corcia P., Fergani A., Gonzalez De Aguilar J.L., Bonnefont-Rousselot D., Bittar R., Seilhean D., Hauw J.J., Lacomblez L., Loeffler J.P., Meininger V. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology 2008, 70:1004-1009.
40. Patel B.P., Hamadeh M.J. Nutritional and exercise-based interventions in the treatment of amyotrophic lateral sclerosis. Clin. Nutr. 2009, 28:604-617.
41. Zinman L., Sadeghi R., Gawel M., Patton D., Kiss A. Are statin medications safe in patients with ALS?. Amyotroph. Lateral Scler. 2008, 9:223-228.